Purpose A history of allergies is associated with a decreased risk of several types of cancers. Potential mechanisms include enhanced immune surveillance against tumor cells early in disease development and/or carcinogenic infectious agents. We tested whether allergies are inversely associated with oral squamous cell carcinoma (OSCC), accounting for factors that may modify the association, such as tumor site, stage, and HPV infection. Methods We estimated odds ratios (OR) and 95 % confidence intervals (CI) for the association between allergy history (including different types of allergies) and OSCC, adjusted for potential confounders, among 400 cases and 613 controls. Analyses were also stratified by site, stage, and measures of HPV infection. Results We observed a weak inverse association between history of any allergy and OSCC (OR = 0.81, 95 % CI 0.61-1.08). This association was present only for allergies to airborne allergens (dust/pollen/mold) (OR = 0.67; 95 % CI 0.48-0.93). The inverse associations with airborne allergies were slightly stronger for oropharyngeal SCC (OR = 0.56; 95 % CI 0.35-0.90) than for oral cavity SCC Conclusion There is an inverse association between history of allergies to dust, pollen, or mold and OSCC. Whether the inverse association involves heightened immune surveillance, increased immune response to HPV or other antigen, or other carcinogenic mechanism remains to be determined in more definitive studies.
Introduction
History of any type of allergy, or allergy-related condition such as asthma, is associated with a decreased risk of multiple types of cancers, including colorectal [1, 2] , cervical [3, 4] , esophageal [2, 5] , laryngeal [2, 3, 6] , pancreatic [7, 8] , and stomach [9] , as well as leukemia [10, 11] and glioma [12] . However, some studies report that history of allergies may increase the risk of certain other types of cancers, such as bladder [6] and prostate [13] cancer. Results are conflicting for breast [9, 13] and lung cancer [6, 14, 15] .
Multiple theories have been proposed to explain an inverse relationship between allergies and cancer. First, having a history of allergies may be indicative of enhanced immune surveillance against nascent tumors and/or infectious agents [16] [17] [18] [19] [20] . Second, according to the ''prophylaxis hypothesis'', allergy symptoms physically rid exposed tissues of potentially mutagenic toxins, pathogens, and foreign particles before carcinogenesis is initiated [21, 22] . Third, allergy symptoms may provide an indication as to which antigens should be avoided, leading to behavioral changes that may result in diminished exposure to carcinogens [22] [23] [24] .
Michaud et al. [25] recently reported a lower risk of head and neck squamous cell carcinoma (HNSCC) associated with history of allergies. Previous hospital-based studies also suggested an inverse association between history of allergies and oral cancer risk [2, 3] . An increasing proportion of oral cancers, those arising in the oropharynx, are attributable to oncogenic HPV infection. If a history of allergies represents, in part, an immune status capable of countering an HPV infection, we would expect that the association between allergies and oral cancer would be strongest for oropharyngeal cancers and in particular for persons with exposure to oncogenic HPV. Associations with allergies were observed to be slightly stronger for oropharyngeal SCC, but HPV-16 serology status did not confound or modify the association between allergies and HNSCC [25] .
We tested the hypothesis that the risk of oral squamous cell carcinoma (OSCC) is associated with history of allergies in a population-based study, accounting for tumor site and HPV-16 serology status as well as HPV DNA status. Prior studies have not examined the association between OSCC and multiple categories of allergens, such as pollen and mold, in detail. If allergies to particles that are in direct contact with the oral mucosa, such as allergies to airborne molecules, are particularly protective, this could provide support for mechanisms involving behavioral changes or prophylaxis. We thus stratified associations by several different allergen categories. To explore whether an association between allergies and OSCC is related to tumor progression or promotion, we tested whether associations differed by disease stage. We hypothesized that a stronger association between late-stage cancers compared with early-stage cancers would suggest that allergies are a marker of enhanced immune surveillance and greater response to tumor antigens.
Methods

Study population and interview data
We used data and biologic specimens from two populationbased case-control studies that investigated the association between HPV infection and risk of OSCC [26, 27] . Cases were 18-to 65-year-old residents of Washington State diagnosed with incident histologically confirmed OSCC in 1985-1989 and 1990-1995 . We identified cases and determined age, stage, site, and histologic type through the Cancer Surveillance System (CSS), a participant in the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program. Cancer sites included the tongue, gum, floor of mouth, other and unspecified part of the mouth, tonsils, and oropharynx. We used ICD-O codes to classify tumors according to site and histology. The case participation proportions were 54 and 63 % for the first and second study, respectively.
Controls were 18-to 65-year-old Washington State residents with no history of oral cancer between 1985-1989 and 1990-1995 and were recruited by random-digit telephone dialing (RDD). Controls were frequency-matched on age group and sex. The overall response proportions for control subjects were 63 and 61 % for the first and second study, respectively. The protocols for the recruitment of, and data collection from, cases and controls in both studies were approved by the Institutional Review Board of the Fred Hutchinson Cancer Research Center.
As previously described [27] , following written informed consent, we interviewed study participants using a structured questionnaire eliciting demographic characteristics and medical and lifestyle history, for the time period prior to their reference date. The reference date for cases was the month and year of diagnosis, and the reference date for controls was randomly assigned from among case subject diagnosis dates prior to the recruitment of that control subject. Participants were asked whether they had ever had allergies prior to the reference date, and if allergies were reported, the specific allergens, corresponding to 54 possible allergy codes, were recorded under five general headings: (1) foods; (2) pollens, plants, grasses, and trees; (3) medications, drugs, and immunizations; (4) inhalants, molds, dust, animals, and tobacco; and (5) others. Cigarette smoking data included whether a person had ever smoked [100 cigarettes, and details regarding continuous periods during which smoking habits (e.g., packs per day) were relatively unchanged. Episodes were delineated according to the ages at which each subject reported major changes in smoking habits, and these data were used to calculate average number of cigarettes smoked per day, total years of smoking, and total pack-years of cigarette smoking. We ascertained alcohol consumption using a similar approach and calculated lifetime average number of alcoholic beverages consumed per week.
Out of a total of 412 cases and 615 controls across both studies, 400 cases and 613 controls had data on age, sex, race, education, pack-years of smoking, average alcoholic drinks per week, and history of allergies.
Biologic specimens and laboratory methods
For this analysis, we used previously published data on HPV-16 and HSV serologic antibody response in cases and controls as well as HPV DNA typing in tumor tissue from cases in the second study (tumor tissue was not obtained in the first study) [27, 28] . An antibody capture enzymelinked immunosorbent assay (ELISA) was used to test sera for antibody response to HPV type 16 L1 protein capsids (virus-like particles), and a Western blot method was used to test sera for HSV antibody status. We used oligonucleotide primers (MY09/MY11) complementary to highly conserved sequences in the L1 region of HPV to amplify HPV DNA from tumor tissue using the polymerase chain reaction (PCR). Specimens positive for the HPV L1 consensus probes were typed by sequential hybridizations with probes for HPV types 6, 11, 16, 18, 31, 33, and 35. We also used primers complementary to the respective E6 regions of HPV DNA types 6, 11, 16, and 18 in the second study. Blood samples were obtained from 85 % of cases and 85 % of controls in the first study and 92 % of cases and 94 % of controls in the second study. HPV DNA status was determined for 226 of the 300 cases from the second study.
Data analysis
We classified cases and controls as to whether or not they reported any allergy, as well as allergies to common reported allergens: pollens, dust, mold, penicillin, sulfa drugs, cats, dogs, and bee stings. No individual food (milk, chocolate, shellfish, wheat, citrus, eggs, seafood, yeast, and miscellaneous food) was commonly reported as an allergen, so these were grouped together as ''food allergies.'' Associations were also estimated for airborne allergies combined (pollen, dust, or mold), antibiotic allergies combined (penicillin, sulfa drugs, or unspecified), and animal allergies combined (cats, dogs, bee stings, horses, cows, rabbits, or other or all animals). The groupings selected were similar to those used in similar studies [4] . For each allergy or group of allergies, the unexposed comparison group included all subjects without that specific allergy. We repeated these analyses with the unexposed comparison group comprised of subjects who reported no allergies of any type.
We estimated the OR and 95 % CI for the association between history of any allergies (yes/no) and OSCC by fitting unconditional adjusted logistic regression models. We adjusted for age (continuous), sex, race, educational attainment (categorical), pack-years of smoking (continuous), smoking status (ever/never), and average alcoholic drinks per week (continuous). We repeated these analyses for a subset of subjects with data on HPV-16 serology and additionally estimated ORs after adjusting for HPV-16 serology status. To explore differences by tumor site, we estimated ORs for oral cavity cancers and oropharyngeal cancers separately using polytomous logistic regression.
To determine whether the presence of allergies was associated with HPV-16 seropositivity, we investigated the independent association of a history of allergies with HPV-16 seropositivity for cases and controls separately. Although HPV seropositivity is a dynamic result of seroconversion and seroreversion, persistent HPV-16 infection is associated with greater likelihood of being HPV-16 seropositive [29, 30] . If enhanced immunity results in rapid clearance of any HPV infections, we might expect allergic individuals to be less likely to be HPV-16 seropositive.
We compared oncogenic HPV DNA-positive cases with controls and compared HPV DNA-negative cases with controls, repeating these analyses for oropharyngeal cancers separately. We explored effect modification by sex, cigarette smoking, and alcohol consumption. We also stratified by HPV-16 and HSV-1 serology, comparing all cases with controls, as well as oropharyngeal cases only with controls. To statistically assess departures from multiplicative effects, we included product terms in stratified analyses and used a log-likelihood ratio test to compare logistic models with and without the product terms. We used polytomous logistic regression to explore differences by stage (in situ/local vs. regional/distant). We used Stata statistical software (version 11.0, Stata Corp.) for all analyses.
Results
Approximately 62 % of case subjects had oral cavity SCC, and 38 % had oropharyngeal SCC. Case subjects were less likely to have attended college and tended to report lower incomes than control participants (Table 1) . Cases had higher levels of cigarette smoking and alcohol consumption compared with controls. Case subjects were more likely to be HPV-16 seropositive: 59.4 % of oropharyngeal SCC and 48.9 % of oral cavity SCC subjects with serology data were HPV-16 seropositive, compared with 34.7 % of controls.
Approximately 42 % of cases and 50 % of controls reported a history of any allergy. The most common allergies were to airborne agents (dust, pollen, and mold), reported by 21 % of cases and 33 % of controls. Among controls, airborne allergies were not associated with household income or educational attainment. Controls with airborne allergies smoked less: 27 % of those with airborne allergies had greater than 20 pack-years of smoking, compared with 37 % of those without allergies (chisquared p = 0.003). Airborne allergies were not associated with alcohol consumption (chi-squared p = 0.19).
We observed a weak inverse association between history of any allergy and OSCC (OR = 0.81; 95 % CI 0.61-1.08; Table 2 ). This inverse association appeared to be primarily Cancer Causes Control (2012) 23:1911-1919 1913 driven by airborne allergies; that is, allergies to dust (OR = 0.69; 95 % CI 0.42-1.12), pollen (OR = 0.72; 95 % CI 0.51-1.02), and mold (OR = 0.34; 95 % CI 0.14-0.83). Repetition of analyses using subjects with no history of any allergies as the comparison group did not materially change the estimates for each allergy category. There was no inverse association for those with allergies that did not include airborne allergies (OR for any allergies other than airborne relative to those with no history of allergies: 1.06; 95 % CI 0.72-1.56). Additional adjustment for HPV-16 seropositivity did not materially affect the estimates. There was no evidence of effect modification by sex, cigarette smoking, or alcohol consumption (data not shown).
Estimates of the association between history of any allergies and oropharyngeal cancer (OR = 0.84; 95 % CI 0.57-1.25; Table 3 ) were similar to estimates for oral cavity cancer (OR = 0.76; 95 % CI 0.54-1.07). However, we observed somewhat stronger associations between airborne allergies and oropharyngeal cancer (OR = 0.56; For case subjects with HPV DNA results, we observed an inverse association between airborne allergies and oropharyngeal cancer, albeit with very wide confidence intervals (OR = 0.69; 95 % CI 0.39-1.24). The association with airborne allergies was near null for oncogenic HPV DNA-positive oropharyngeal cancer (OR = 0.85; 95 % CI 0.38-1.92; Table 4 ) and inverse for oncogenic HPV DNA-negative oropharyngeal cancer (OR = 0.54; 95 % CI 0.24-1.21). Odds ratios shown in bold are those for which the 95 % confidence intervals exclude the null value Twelve case subjects were missing data on stage of tumor. The association between airborne allergies and OSCC, excluding these twelve subjects, was similar to primary results (OR = 0.66; 95 % CI 0.47-0.92). Out of a total of 388 patients, 182 had in situ/local disease and 206 had regional/distant cancer. We observed a strong inverse association between history of airborne allergies and regional/distant cancer (OR = 0.42; 95 % CI 0.26-0.66) and no association with in situ/local cancer (OR = 0.98; 95 % CI 0.66-1.46). The polytomous regression model indicated significant heterogeneity by stage (p = 0.001).
Discussion
We observed a weak inverse association between history of any allergy and OSCC. The inverse association was strongest for airborne agents (dust, pollens, or mold), and there was no association between other allergies and OSCC.
Pollens made up the largest proportion of airborne allergens. Allergy to pollens was also the strongest driver of an observed inverse association between allergies and cervical cancer [4] . Similarly, pancreatic cancer was inversely associated with dust, plant, mold, and cat allergic reactions, but not other allergens [8] . We also observed inverse associations with cat allergies; however, confidence intervals were too wide to meaningfully interpret the estimates. Other studies have examined specific allergic reactions such as hay fever, asthma, eczema, and hives, associated with various cancers. Hay fever is most commonly reported in association with reduced risk of cancers, although this finding is not entirely consistent (see Merrill et al. [31] and Turner et al. [32] for a review).
Three prior studies have investigated the association of allergies with oral cancer. In a hospital-based case-control study using questionnaire data, Vena et al. [3] observed inverse associations with oral cancer in males who reported asthma (OR = 0.82), hay fever (OR = 0.49, p \ 0.05), hives (OR = 0.60), or other allergies (OR = 0.53, p \ 0.05). In a hospital-based investigation pooling data from several case-control studies, Bosetti et al. [2] observed an inverse association between conditions such as allergic rhinitis, asthma, and atopic dermatitis, and oral/ pharyngeal cancer (OR = 0.44; 95 % CI, 95 % CI 0.26-0.75); results for specific allergies were not reported. In a recent population-based study of 1,014 cases and 1,193 controls, Michaud et al. [25] observed an inverse Odds ratios shown in bold are those for which the 95 % confidence intervals exclude the null value association between self-reported history of allergies and HNSCC (OR = 0.81; 95 % CI 0.67-0.98). It is notable that we observed the same association estimate, but with wider confidence intervals (OR = 0.81, 95 % CI 0.61-1.08). In contrast to our results, they did not observe a difference in association by type of allergy. However, they did not have detailed allergen data and categorized type of allergy as ''food'', ''seasonal,'' or ''drug'' allergies, whereas we recorded specific allergens, corresponding to 5 categories and 54 possible codes, such as pollens, mold, cats, etc. We hypothesized that enhanced immune function associated with allergies may be a surrogate for other immune functions that lead to reduced risk of OSCC by inducing clearance of oncogenic HPV before infection becomes established, thereby reducing the incidence of a proportion of oropharyngeal SCC. However, as was also observed by Michaud et al. [25] , associations stratified by HPV-16 serostatus did not provide support for this hypothesis. There was some indication of a stronger inverse association between airborne allergies and oropharyngeal cancer among HPV-seronegative subjects compared with HPVseropositive subjects; however, this was likely due to chance because of very small numbers of subjects.
The association with airborne allergies was near null for oncogenic HPV DNA-positive oropharyngeal SCC and stronger for oncogenic HPV DNA-negative oropharyngeal SCC. However, due to the relatively small number of oropharyngeal cases, our study lacked power to detect differences by HPV status if they exist. Unmeasured confounding factors or imperfect adjustment for confounders, such as pack-years of smoking, might also explain why a stronger association was observed for oncogenic HPV DNA-negative oropharyngeal SCC. Cases with HPV-negative oropharyngeal cancer were much more likely to be heavy smokers (87 % with [20 pack-years of smoking) than cases with HPV-positive oropharyngeal cancer (40 % with [20 pack-years of smoking), but subjects with allergies were less likely to be heavy smokers, which may increase the relative influence of confounding in associations between allergies and HPV-negative oropharyngeal cancer.
We previously reported an increased risk of OSCC, and oropharyngeal cancer in particular, associated with seropositivity to HSV-1 [28] and examined these data as part of testing our hypothesis regarding the possible role of oncogenic infections in the relationship between allergies and oropharyngeal cancer. We found no evidence that the association between oropharyngeal cancer risk and allergy history depended on HSV-1 serostatus. Importantly, other investigators have not observed positive associations between HSV-1 and oral cancer, whether overall or by site [33, 34] .
We observed a slightly stronger inverse association between airborne allergies and oropharyngeal cancer, compared with oral cavity cancer; however, results from a polytomous regression analysis suggest that this could be due to chance. Michaud et al. [25] noted an association between allergies and oropharyngeal cancer (OR = 0.73, 95 % CI = 0.57-0.92), but no association with oral cavity cancer (OR = 0.98, 95 % CI = 0.76-1.26). An inverse association that was particularly apparent for oropharyngeal SCC would be consistent with heightened immune surveillance in people with allergies, as the oropharynx contains a large collection of lymphatic tissue, which plays an important role in immune surveillance. Also, partially in support of the hypothesis of enhanced immune surveillance and greater response to tumor antigens, we observed a strong inverse association between airborne allergies and later-stage OSCC (regional/distant) and no association with earlier-stage OSCC (in situ/local). This suggests that characteristics associated with the presence of allergies play a role in protection against tumor progression/ promotion.
The ''prophylaxis'' theory, whereby allergy symptoms expel carcinogenic agents from exposed tissues, remains a possible mechanism for an inverse association between airborne allergies and OSCC. The oral mucosa interacts directly with the external environment, and inverse relationships between allergies and various cancers have been more frequently observed for sites in direct contact with the environment [22] . In addition, inverse relationships with cancers have more frequently been reported for hay fever and animal allergies than for drug allergies [22] .
A final possibility that may account for our results is that allergies affect lifestyle choices [23, 24] . Avoidance of certain allergy triggers, including air pollutants or dietary constituents, may produce a self-selective reduction in exposure to environmental carcinogens. This may be particularly relevant for smoking, which is a major risk factor for OSCC. If this is the case, since smoking status is directly affected by the presence of allergies, and is a strong risk factor for OSCC, estimates without adjustment for smoking may be appropriate. However, associations with airborne allergies that are adjusted for all other potential confounders are similar with (OR = 0.67; 95 % CI 0.48-0.93) and without (OR = 0.63; 95 % CI 0.46-0.87) adjustment for pack-years of smoking and smoking status (ever/never).
A limitation of this study is that we were only able to examine self-reported allergy history. Nevertheless, the prevalence of allergies among controls (50 % for any allergy and 33 % for airborne allergies) is in line with data from the NHANES III study, which reported a 54 % positive skin prick test for ''any allergy'' and a 40 % positive skin prick test for ''outdoor'' allergens [35] .
However, it is possible that non-airborne allergies may have been over-reported. Allergies to pollen, mold, and dust are the most common allergies reported, and given that reactions to airborne allergens such as allergic rhinitis are overt and generally unmistakable, these allergies may be less likely to be confused with non-allergic conditions. However, conditions such as food intolerances may mistakenly be considered to be allergies. Such non-differential misclassification would bias results for food allergies closer to the null, raising the possibility that underlying true inverse associations may be of magnitude similar to allergies to airborne agents. Recall bias may be a possibility if cases were more likely to report allergies; however, we then would be less likely to observe inverse associations with OSCC.
The participation proportions were fairly low (54.4 and 63.3 % of cases and 63 and 61 % of controls for the first and second study, respectively). Although there is a possibility that participants may differ from non-participants in their exposure history, this is likely to be non-differential based on case-control status for an exposure such as allergies; thus, results would likely be biased toward the null. If a bias does exist, there is a possibility that true estimates may in fact be stronger than those observed. A reason for the low participation rate in the first study is that almost one-fourth of eligible cases died before recruitment [26] . Thus, case participants may have been less likely to have later-stage disease than non-participants, and we observed a stronger association between airborne allergies and later-stage disease compared with earlier-stage disease.
Our ability to accurately assess the relevance of HPV infection with respect to the association between allergies and OSCC was hindered by limitations of both HPV serology and HPV DNA measurement. PCR amplification of HPV DNA may often yield false-positive results [36] or merely reflect a transient infection, with no involvement in the carcinogenic process [37] . On the other hand, measurement of paraffin-embedded tissue, as was used in the present study, may underestimate the proportion of tumors containing HPV DNA because of degradation of specimens [38] . In addition, the dynamics of HPV seroconversion and the extent of antibody response to HPV type 16 capsids resulting specifically from oral HPV infection are unknown. We measured HPV-16 L1 antibodies, but not E6/ E7 antibodies, because L1 antibodies are markers of prior infection, while E6/E7 antibodies are indicative of the presence of HPV-related cancer [39] [40] [41] ; however, sensitivity of HPV L1 antibodies is estimated to be only 50-70 % [39] . Measurement issues are not expected to differ between cases and controls; however, misclassification of HPV status by serology or DNA measures would impact the ability to accurately categorize subjects and thus limit the ability to detect any hypothesized heterogeneity by HPV status.
Conclusion
In this population-based case-control study, we observed a weak inverse association between a history of allergies and OSCC, adjusted for potential confounders. The association with OSCC was particularly strong for allergies to dust, pollen, and mold. Large-scale prospective studies, including biomarkers such as skin prick testing and IgE levels [32, 42] , are needed to better characterize the association and provide insights into potential biologic mechanisms.
